Vasomotor rhinitis.
Vasomotor rhinitis affects millions of Americans and results in significant symptomatology. Characterized by a combination of symptoms that includes nasal obstruction and rhinorrhea, vasomotor rhinitis is a diagnosis of exclusion reached after taking a careful history, performing a physical examination, and, in select cases, testing the patient with known allergens. According to a 2002 evidence report published by the Agency for Healthcare Research and Quality (AHRQ), there is insufficient evidence to reliably differentiate between allergic and nonallergic rhinitis based on signs and symptoms alone. The minimum level of diagnostic testing needed to differentiate between the two types of rhinitis also has not been established. An algorithm is presented that is based on a targeted history and physical examination and a stepwise approach to management that reflects the AHRQ evidence report and U.S. Food and Drug Administration approvals. Specific approaches to the management of rhinitis in children, athletes, pregnant women, and older adults are discussed.
Wheeler
Patricia W
PW
Department of Family and Geriatric Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40218, USA.
Wheeler
Stephen F
SF
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000465:Algorithms; D002648:Child; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D012220:Rhinitis / Q000145:classification / Q000188:drug therapy / Q000209:etiology
D000305:Adrenal Cortex Hormones; D006634:Histamine H1 Antagonists